{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:43:25Z","timestamp":1793457805158,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16F16385"],"award-info":[{"award-number":["16F16385"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijbiomac.2024.139320","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T01:38:41Z","timestamp":1735436321000},"page":"139320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of benzimidazole-6-carboxamide based inhibitors of secretory glutaminyl cyclase for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"293","author":[{"given":"K.V.","family":"Dileep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya M.","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Wai","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam Y.J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.139320_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer's disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"issue":"10 Suppl","key":"10.1016\/j.ijbiomac.2024.139320_bb0010","first-page":"S188","article-title":"The economic and societal burden of Alzheimer disease: managed care considerations","volume":"28","author":"Skaria","year":"2022","journal-title":"Am. J. Manag. Care"},{"issue":"8 Suppl","key":"10.1016\/j.ijbiomac.2024.139320_bb0015","first-page":"S177","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.139320_bb0025","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/alz.12127","article-title":"How can population-based studies best be utilized to reduce the global impact of dementia?","volume":"16","author":"Stephan","year":"2020","journal-title":"Recommendations for researchers, funders, and policymakers, Alzheimers Dement"},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0030","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.945091","article-title":"A review of the current status of disease-modifying therapies and prevention of Alzheimer\u2019s disease","volume":"30","author":"Parums","year":"2024","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-030-42667-5_8","article-title":"Early diagnosis and targeted treatment strategy for improved therapeutic outcomes in Alzheimer\u2019s disease","volume":"1260","author":"Guest","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2024.139320_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000347140","article-title":"Adherence to cholinesterase inhibitors in Alzheimer\u2019s disease: a review","volume":"35","author":"Brady","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139320_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for Alzheimer\u2019s disease in clinical trials","volume":"68","author":"Godyn","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139320_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1533317515622283","article-title":"Toxicological differences between NMDA receptor antagonists and cholinesterase inhibitors","volume":"31","author":"Shi","year":"2016","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.139320_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer\u2019s disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139320_bb0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"5054","key":"10.1016\/j.ijbiomac.2024.139320_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.139320_bb0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000007969","article-title":"Neurofibrillary tangles and Alzheimer\u2019s disease","volume":"40","author":"Brion","year":"1998","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.139320_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1357-4310(98)01229-5","article-title":"Molecular pathogenesis of sporadic and familial forms of Alzheimer\u2019s disease","volume":"4","author":"Ray","year":"1998","journal-title":"Mol. Med. Today"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.139320_bb0080","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0091-3057(96)00431-5","article-title":"Acetylcholine, aging, and Alzheimer\u2019s disease","volume":"56","author":"Muir","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139320_bb0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.139320_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139320_bb0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.139320_bb0100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/jnr.22392","article-title":"Synapse loss in dementias","volume":"88","author":"Clare","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.139320_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.139320_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jnc.12304","article-title":"Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer\u2019s disease","volume":"126","author":"Paula-Lima","year":"2013","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139320_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139320_bb0120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1098-1063(1998)8:5<526::AID-HIPO10>3.0.CO;2-V","article-title":"Synchronous modulation of perirhinal cortex neuronal activity during cholinergically mediated (type II) hippocampal theta","volume":"8","author":"Muir","year":"1998","journal-title":"Hippocampus"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.139320_bb0125","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.695808","article-title":"APP, PSEN1, and PSEN2 variants in Alzheimer\u2019s disease: systematic re-evaluation according to ACMG guidelines","volume":"13","author":"Xiao","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-7091-6467-9_11","article-title":"Evolution of neuronal changes in the course of Alzheimer\u2019s disease","volume":"53","author":"Braak","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0140","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"N Y) 9(2","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.139320_bb0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrneurol.2017.147","article-title":"A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.139320_bb0150","first-page":"8532","article-title":"An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides","volume":"262","author":"Busby","year":"1987","journal-title":"Presence in pituitary, brain, adrenal medulla, and lymphocytes, J Biol Chem"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.139320_bb0155","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.84.11.3628","article-title":"Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides","volume":"84","author":"Fischer","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0160","doi-asserted-by":"crossref","unstructured":"G.N. Abraham, D.N. Podell, Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal, Mol Cell Biochem 38 Spec No(Pt 1) (1981) 181\u201390.","DOI":"10.1007\/BF00235695"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.139320_bb0165","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jmb.2008.03.078","article-title":"Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery","volume":"379","author":"Cynis","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.139320_bb0170","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1111\/j.1742-4658.2009.07337.x","article-title":"Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics","volume":"276","author":"Stephan","year":"2009","journal-title":"FEBS J."},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.139320_bb0175","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1074\/jbc.M111.229385","article-title":"Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development","volume":"286","author":"Schilling","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104342","article-title":"Human glutaminyl cyclase: structure, function, inhibitors and involvement in Alzheimer\u2019s disease","volume":"147","author":"Vijayan","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.139320_bb0185","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1021\/acs.jmedchem.4c00049","article-title":"X-ray structure-guided discovery of a potent Benzimidazole Glutaminyl cyclase inhibitor that shows activity in a Parkinson\u2019s disease mouse model","volume":"67","author":"Mou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijbiomac.2020.12.118","article-title":"Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors","volume":"170","author":"Dileep","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.139320_bb0195","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1074\/jbc.M110.208595","article-title":"Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.139320_bb0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"Pt 8","key":"10.1016\/j.ijbiomac.2024.139320_bb0205","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1107\/S2053230X15010389","article-title":"The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease","volume":"71","author":"DiPisa","year":"2015","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10.1016\/j.ijbiomac.2024.139320_bb0210","doi-asserted-by":"crossref","unstructured":"W. Kabsch, Xds, Acta Crystallogr. D Biol. Crystallogr. 66(Pt 2) (2010) 125\u201332.","DOI":"10.1107\/S0907444909047337"},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2024.139320_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2024.139320_bb0220","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Cryst."},{"issue":"Pt 12 Pt 1","key":"10.1016\/j.ijbiomac.2024.139320_bb0225","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 11","key":"10.1016\/j.ijbiomac.2024.139320_bb0230","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2024.139320_bb0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.139320_bb0240","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00775-018-1605-1","article-title":"The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders","volume":"23","author":"Pozzi","year":"2018","journal-title":"J. Biol. Inorg. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024101316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024101316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:49:26Z","timestamp":1782899366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024101316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":48,"alternative-id":["S0141813024101316"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139320","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of benzimidazole-6-carboxamide based inhibitors of secretory glutaminyl cyclase for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"139320"}}